Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The trial is designed to show the effect of treatment with
liraglutide or placebo on blood glucose control after 14 weeks in subjects with type 2
diabetes. Liraglutide or placebo is administered by injection once daily in the evening. The
trial is a multi-national trial with treatment concealed to participating subjects,
investigators and the sponsor. Treatment allocation is random with equal chance of being
assigned to each group.